MORE►
NanOlogy
NanOlogy Fractional Chief Medical Officer John Goldberg, MD [Composite image; source: John Goldberg/LinkedIn]
NanOlogy Names Biotech Veteran as Fractional Chief Medical Officer
by David Seeley | Jan 7, 2026
John M. Goldberg, MD, has had recent CMO roles at Rafael Holding, a healthcare investment, family office, and biotechnology company, and at Oncorus, a biopharmaceutical company developing an intratumorally delivered viral immunotherapy for cancer.
by Sandra Engelland |
Dec 30, 2025
The Fort Worth oncology company tapped former Salarius Pharmaceuticals CEO David Arthur to lead its push toward commercialization, including a planned IND for a rare pediatric brain cancer program.
MORE►
by Lance Murray |
Mar 7, 2023
NanOlogy said the new patent covers a method of treating cancer by intratumoral administration of large surface area microparticle taxanes in combination with systemic administration of immune checkpoint inhibitors. “The goal is to identify which combinations can increase the immune response, thereby increasing the overall solid tumor response to treatment," said NanOlogy Chief Medical Officer Gere DiZerega.
MORE►
by Quincy Preston |
Nov 20, 2022
Fort Worth-based NanOlogy has completed the enrollment of 18 patients in a Phase 2a trial for its proprietary particle drug delivery with standard-of care therapy in nonoperable lung cancer patients....
MORE►
Discovery: Blood Plasma and Alzheimer’s, NanOlogy’s Ovarian Cancer Trial & Studying Hurricane Debris
by Lance Murray | Oct 13, 2017
Researchers across North Texas are doing cutting-edge work in a variety of fields — from medicine to weather. Here are some examples.
MORE►
by Lance Murray |
Sep 13, 2017
The technique uses "naked" nanoparticles that can be injected directly into a tumor for greater efficacy and safety.
MORE►
